Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety.
Int Arch Med. 2012 Feb 8;5(1):5. [Epub ahead of print] Paz Rodriguez J, Murphy MP, Hong S, Madrigal M, March KL, Minev B, Harman RJ, Chen CS, Timmons RB, Marleau AM, Riordan NH. ABSTRACT: Advancements in rheumatoid arthritis (RA) treatment protocols and introduction of targeted biological therapies have markedly improved patient outcomes, despite this, up [...]